Technology

  Market Overview According to Market Genics , the AI in Pharmacovigilance Market is estimated to be valued at USD 0.4 Billion in 2025 and is projected to reach USD 1.9 Billion by 2035 , registering a CAGR of 17.1% during the forecast period. The market is experiencing rapid growth due to the increasing demand for automated drug safety monitoring, rising volumes of adverse event reports, and g rowing adoption of artificial intelligence across the pharmaceutical industry. AI-powered pharmacovigilance solutions leverage machine learning (ML), natural language processing (NLP), robotic process automation (RPA), predictive analytics, and cloud computing to streamline adverse event detection, case processing, signal management, and regulatory reporting. The increasing complexity of global drug development, stringent regulatory requirements, expanding real-world evidence (RWE) initiatives, and the growing use of electronic health records (EHRs) are accelerating the adoption of ...